CRIS Current Research Information System

VITALI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.595
NA - Nord America 13.279
AS - Asia 12.593
AF - Africa 943
SA - Sud America 664
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 10
Totale 46.118
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.017
IT - Italia 10.799
CN - Cina 3.302
SG - Singapore 3.214
VN - Vietnam 2.742
GB - Regno Unito 2.135
DE - Germania 1.217
HK - Hong Kong 918
SE - Svezia 911
FR - Francia 727
IN - India 627
NL - Olanda 556
BR - Brasile 473
RU - Federazione Russa 447
UA - Ucraina 384
BD - Bangladesh 355
IE - Irlanda 301
KR - Corea 256
JP - Giappone 243
CI - Costa d'Avorio 227
ZA - Sudafrica 224
PK - Pakistan 171
FI - Finlandia 166
CA - Canada 157
TG - Togo 144
CH - Svizzera 124
EE - Estonia 113
ID - Indonesia 108
PL - Polonia 101
NG - Nigeria 93
SC - Seychelles 92
BE - Belgio 90
AR - Argentina 86
ES - Italia 80
TR - Turchia 77
PH - Filippine 75
BG - Bulgaria 71
TH - Thailandia 68
IR - Iran 67
JO - Giordania 66
GR - Grecia 62
TW - Taiwan 58
IQ - Iraq 55
EG - Egitto 53
HR - Croazia 52
MX - Messico 52
AT - Austria 41
DZ - Algeria 37
RO - Romania 33
MY - Malesia 32
SA - Arabia Saudita 31
CL - Cile 28
UZ - Uzbekistan 28
AU - Australia 27
PT - Portogallo 23
DK - Danimarca 21
LB - Libano 18
SM - San Marino 18
CZ - Repubblica Ceca 17
MA - Marocco 17
CO - Colombia 16
LT - Lituania 15
PE - Perù 15
RS - Serbia 15
SK - Slovacchia (Repubblica Slovacca) 14
NO - Norvegia 13
EC - Ecuador 12
VE - Venezuela 12
AL - Albania 10
HU - Ungheria 10
UY - Uruguay 10
IL - Israele 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
GH - Ghana 8
KZ - Kazakistan 8
TN - Tunisia 8
ET - Etiopia 7
KE - Kenya 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
BB - Barbados 6
OM - Oman 6
SI - Slovenia 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
PS - Palestinian Territory 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CM - Camerun 4
LU - Lussemburgo 4
MT - Malta 4
QA - Qatar 4
BZ - Belize 3
CR - Costa Rica 3
GE - Georgia 3
Totale 46.040
Salva come PNG Salva come JPEG
Città #
Singapore 2.182
Southend 1.762
Ashburn 1.495
Bologna 929
Hong Kong 842
San Jose 842
Chandler 817
Milan 791
Fairfield 759
Rome 716
Ho Chi Minh City 619
Hefei 548
Santa Clara 546
Hanoi 530
Wilmington 424
Seattle 389
Beijing 387
Ann Arbor 384
Princeton 379
Woodbridge 363
Houston 361
Dallas 342
Los Angeles 314
Boardman 310
Dublin 289
Cambridge 286
Naples 282
Frankfurt am Main 280
New York 274
Abidjan 227
Seoul 222
Dong Ket 218
Turin 213
Lauterbourg 206
Council Bluffs 205
Florence 197
Jacksonville 195
Padova 192
Tokyo 181
Nanjing 179
Westminster 156
Lomé 144
Berlin 142
Buffalo 136
Helsinki 121
Bari 108
Modena 107
Jinan 102
Catania 101
Da Nang 97
Redmond 92
Shanghai 88
Palermo 87
Medford 85
Saint Petersburg 85
Cesena 84
Guangzhou 84
Shenyang 80
Haiphong 78
São Paulo 78
Lahore 73
Redondo Beach 73
Abeokuta 72
Bengaluru 70
Orem 67
San Diego 67
Sofia 67
Verona 67
Chicago 66
Dearborn 66
Nanchang 66
Tianjin 65
Amman 64
Munich 62
Rimini 62
Changsha 59
Johannesburg 59
Amsterdam 57
Phoenix 57
Hebei 56
London 56
San Francisco 56
Falls Church 55
Bern 54
Brussels 53
Genoa 53
Pescara 53
Jakarta 52
Perugia 50
Gujranwala 49
Redwood City 48
Denver 46
Padua 46
Parma 46
Mülheim 45
Toronto 45
Zhengzhou 44
Atlanta 42
Forlì 42
Montreal 42
Totale 25.004
Salva come PNG Salva come JPEG
Nome #
VSL#3 in gravidanza: impatto sul microbiota e sulla risposta immune vaginale 7.087
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 743
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 741
Lactobacillus Biofilms Influence Anti-Candida Activity 734
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 690
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 495
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 410
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 354
Inserti vaginali mucoadesivi costituiti da complessi di chitosano e alginato per il rilascio locale di clorexidina digluconato 321
Identification of vaginal bacteria 307
Isolation of vaginal lactobacilli and characterization of anti-candida activity 303
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 300
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 289
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 283
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 280
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 276
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 272
Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration 268
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 259
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 259
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 258
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 249
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota 248
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 248
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity 245
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 236
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 228
Development of azithromycin-loaded microemulsions for the treatment of skin infections 227
Characterization and Heterologous Expression of the Oxalyl Coenzyme A Decarboxylase Gene from Bifidobacterium lactis 227
Diversity of vaginal microbiome and metabolome during genital infections 227
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 226
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 223
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 221
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 219
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 217
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 217
Investigation on the effects of antimicrobial imidazo[2,1-b]thiazole derivatives on the genitourinary microflora 215
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina 214
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR 213
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 212
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 212
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 211
High-dose probiotics for the treatment of active pouchitis 210
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali 208
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system 207
Novel probiotic candidates for humans isolated from raw fruits and vegetables 207
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 206
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 205
Designing fermented milk with targeted probiotics: a step toward female-focused functional foods 204
Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate 204
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 204
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 202
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 202
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 200
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 200
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 199
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 199
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 199
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 196
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 190
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 190
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy 187
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 185
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride 185
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 183
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 182
In-vitro effect of vaginal lactobacilli against group B Streptococcus 182
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system-authors' response 180
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 180
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 179
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens 179
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion 179
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 179
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 176
A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry 176
Method for diagnosis vaginal infections 175
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 173
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 173
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 173
Human Breast Milk: A Source of Potential Probiotic Candidates 172
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. 171
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 171
Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo 170
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 169
Metabolic profiling of Candida clinical isolates of different species and infection sources 168
Bifidobacterium lactis Enolase, surface localization and mechanism of interaction with human Plasminogen 167
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota 167
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis 167
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 167
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 167
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 167
High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. 166
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 166
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 166
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real time PCR study 165
Correlation of Atopobium vaginae amount with bacterial vaginosis markers 164
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 163
Protocol for the Use of PCR-Denaturing Gradient Gel Electrophoresis and Quantitative PCR to Determine Vaginal Microflora Constitution and Pathogens in Bacterial Vaginosis 162
Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate 161
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 161
Totale 30.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021876 0 0 0 0 0 0 0 0 0 0 0 876
2021/20224.084 336 194 237 241 434 253 201 307 200 312 769 600
2022/20235.233 492 619 271 542 391 417 289 334 801 284 446 347
2023/20243.488 250 348 273 319 314 526 228 202 204 337 237 250
2024/20258.160 446 942 817 661 1.014 534 851 470 338 495 466 1.126
2025/202616.767 1.248 1.478 1.331 1.112 1.531 868 1.977 681 2.577 1.325 1.659 980
Totale 46.948